---
schema_version: "secwatch.filing_event.v1"
accession: "0001091818-21-000150"
form_type: "8-K"
ticker: "BFNH"
cik: "0001310488"
company_name: "BIOFORCE NANOSCIENCES HOLDINGS, INC."
filed_at: "2021-11-30T23:59:59+00:00"
generated_at: "2026-06-28T04:47:39.323710+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioForce Nanosciences appoints Co-CEOs and President, CEO Merle Ferguson resigns

## Summary
- CEO & President Merle Ferguson resigned Nov 30, 2021; remains Chairman, no dispute with company.
- Steve Gagnon and John LaViolette appointed Co-CEOs effective Nov 30, 2021.
- Sasha Shapiro appointed President effective Nov 30, 2021.
- New officers are from Element Global (OTC Pink) and have entertainment industry backgrounds.

## SEC filing metadata
- accession: 0001091818-21-000150
- form_type: 8-K
- ticker: BFNH
- cik: 0001310488
- company_name: BIOFORCE NANOSCIENCES HOLDINGS, INC.
- filed_at: 2021-11-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1310488/000109181821000150/0001091818-21-000150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1310488/000109181821000150/bfnh8k2021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001091818-21-000150
- JSON: https://secwatch.observer/filing/0001091818-21-000150.json
- Plain text: https://secwatch.observer/filing/0001091818-21-000150.txt

## Key facts
- Executive change
  Merle Ferguson resigned as Chief Executive Officer and President at BIOFORCE NANOSCIENCES HOLDINGS, INC..
  - Action: resigned
  - Role: Chief Executive Officer and President
  source text: the Board of Directors accepted the resignation of Mr. Merle Ferguson as Chief Executive Officer and President, effective November 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1310488/000109181821000150/0001091818-21-000150-index.htm
- Executive change
  John LaViolette was appointed as Co-Chief Executive Officer at BIOFORCE NANOSCIENCES HOLDINGS, INC..
  - Action: appointed
  - Role: Co-Chief Executive Officer
  source text: appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1310488/000109181821000150/0001091818-21-000150-index.htm
- Executive change
  Sasha Shapiro was appointed as President at BIOFORCE NANOSCIENCES HOLDINGS, INC..
  - Action: appointed
  - Role: President
  source text: appointed Sasha Shapiro as President, effective November 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1310488/000109181821000150/0001091818-21-000150-index.htm
- Executive change
  Steve Gagnon was appointed as Co-Chief Executive Officer at BIOFORCE NANOSCIENCES HOLDINGS, INC..
  - Action: appointed
  - Role: Co-Chief Executive Officer
  source text: appointed both Mr. Steve Gagnon and Mr. John LaViolette as Co-Chief Executive Officers (Co-CEOs), effective November 30, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1310488/000109181821000150/0001091818-21-000150-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.